June 24, 2020
Targovax announces presentation of pre-clinical data from Next Generation ONCOS at AACR Virtual Annual Conference
Media
June 23, 2020
Vicore Pharma expands recruitment base for the ATTRACT study
June 23, 2020
Targovax announces collaboration to evaluate ONCOS-102 in combination with KEYTRUDA® in mesothelioma
June 22, 2020
Vicore Pharma’s drug candidate VP01 demonstrates potential for significant benefit in severe pulmonary hypertension
June 22, 2020
Targovax to present at the upcoming 2020 Virtual European Biotech Investor Day 2020
June 22, 2020
Targovax’s ONCOS-102 mesothelioma 12-month data powerfully demonstrate broad immune activation linked to clinical benefit
June 18, 2020
Orexo – in Wired Magazine
June 17, 2020
Orexo and Lyfebulb Announce Call for Digital Solutions to Treat Substance Use Disorder
June 15, 2020
BONESUPPORT FORTIFY PATIENT ENROLLEMENT FINALIZED EARLIER THAN ORIGINAL PLAN
June 15, 2020
Oncopeptides reports positive results from full data set of Phase 2 HORIZON trial in triple-class refractory multiple myeloma patients